Cargando…
Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study
BACKGROUND: The results of clinical trials should be completely and rapidly reported during public health emergencies such as COVID-19. This study aimed to examine when, and where, the results of COVID-19 clinical trials were disseminated throughout the first 18 months of the pandemic. METHODS: Clin...
Autores principales: | Salholz-Hillel, Maia, Pugh-Jones, Molly, Hildebrand, Nicole, Schult, Tjada A., Schwietering, Johannes, Grabitz, Peter, Carlisle, Benjamin Gregory, Goldacre, Ben, Strech, Daniel, DeVito, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687901/ https://www.ncbi.nlm.nih.gov/pubmed/38031096 http://dx.doi.org/10.1186/s12916-023-03161-6 |
Ejemplares similares
-
Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study
por: Salholz-Hillel, Maia, et al.
Publicado: (2021) -
Results publications are inadequately linked to trial registrations: An automated pipeline and evaluation of German university medical centers
por: Salholz-Hillel, Maia, et al.
Publicado: (2022) -
Institutional dashboards on clinical trial transparency for University Medical Centers: A case study
por: Franzen, Delwen L., et al.
Publicado: (2023) -
Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study
por: DeVito, Nicholas J, et al.
Publicado: (2022) -
158 Hepatitis C Treatment Update: Current Status and Future Direcctions
por: Kottilil, Shyam
Publicado: (2014)